We have secured competitive edge in the Red Bio market,
based on our superior technologies and R&D capabilities.
Based on our superior biotechnology and R&D capabilities accumulated since 1980s,
we have been successful in developing a variety of original products including Korea's
first growth hormone for children, new drugs for diabetes, etc. At the same time,
we have continuously expanded our competitive edge through cooperation with global
Growth Stimulation, Infertility Treatment, Renal Diseases, Biosimilar, etc.
Musculoskeletal Diseases, Cosmetic Surgery
Diabetes, Cardiovascular Drugs
Immunodiagnosis, Molecular Diagnosis
EutropinGrowth hormone deficiency
Zemiglo / Zemimet SR Tab.Non-insulin dependent diabetes mellitus
FollitropeInduction of ovulation
EspogenAnemia in patients with chronic renal failure